Lymphomatoid Granulomatosis with Central Nervous System Involvement Successfully Treated with Cyclophosphamide, High-dose Cytarabine, Dexamethasone, Etoposide, and Rituximab (CHASER therapy) Followed by Brain Irradiation: A Case Study.

Authors	Motoki Fujimaki, Sumihiro Kawajiri, Kunimoto Ichikawa, Yuji Tomizawa, Tomoko Nakazato, Kazuyuki Noda, Nobutaka Hattori, Michiaki Koike, Yasuyuki Okuma
Journal	CNS neuroscience & therapeutics (CNS Neurosci Ther) Vol. 21 Issue 7 Pg. 610-2 (Jul 2015) ISSN: 1755-5949 [Electronic] England
PMID	26096049 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
Chemical References	Antineoplastic Agents Cytarabine Rituximab Etoposide Dexamethasone Cyclophosphamide
Topics	Adult Antineoplastic Agents (therapeutic use) Central Nervous System Neoplasms (drug therapy) Combined Modality Therapy Cyclophosphamide (therapeutic use) Cytarabine (therapeutic use) Dexamethasone (therapeutic use) Etoposide (therapeutic use) Female Humans Lymphomatoid Granulomatosis (drug therapy, radiotherapy) Rituximab (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!